We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Laboratory Information Management System Designed to Manage, Share Data More Effectively

By LabMedica International staff writers
Posted on 23 Oct 2008
A zero-footprint laboratory information-management system has been customized to manage an organization's vital laboratory information across its worldwide operations to optimize productivity and share knowledge more effectively. More...


LabVantage Solution, Inc. (Bridgewater, NJ, USA) recently reported that its Sapphire laboratory information management suite (LIMS) has been awarded the caBIG (cancer Biomedical Informatics Grid) Bronze Compatibility Certification by the U.S. National Cancer Institute Center for Bioinformatics (NCICB; Rockville, MD, USA).

Sponsored by U.S. National Cancer Institute (NCI; Rockville, MD, USA),
caBIG is a network created by biomedical informaticists, researchers, physicians, patients, and others to establish an interoperable information infrastructure. The caBIG certification program is designed for software system certification; thus, Sapphire satisfies the requirements, including: programming and messaging interfaces that allow programmatic access to data from an external resource; vocabularies/terminologies that permit use of publicly accessible controlled vocabularies as well as local terminologies; data elements that maintain sufficient data element description, built using controlled terminology with accurate metadata storage; and information models that provide an electronic diagrammatic representation of the information model.

"More and more cancer and translational research organizations, such as NCI and its designated research centers, are seeking to standardize their laboratory informatics solutions to facilitate knowledge sharing, and in turn, achieve research success,” stated Terry Smallmon, director of life sciences at LabVantage. "For example, as part of the caBIG-certified Sapphire Suite, the Sapphire BioBanking solution is of critical importance to organizations needing to establish standardized information technology solutions for their biorepositories or biobanks.”

LabVantage's Sapphire BioBanking system has not only been selected to support the NCI Cancer Genome Atlas Biospecimen Core Resource, but has been adopted by numerous other institutions worldwide. The system is well recognized as the industry-leading thin-client LIMS and the major biobanking solution for numerous institutions. "The Bronze Certification of Sapphire, the first LIMS and the only pure zero-footprint solution to achieve this distinction, is another validation of our continuous commitment to adopt informatics standards and be at the forefront of best-in-breed technology, functionality, and flexibility,” remarked Jim Aurelio, CEO and president of LabVantage. "With Sapphire, we enable a truly collaborative and compliant environment for scientific research organizations, both inside and outside of the NCI community.”

LabVantage is a global provider of enterprise solutions customized for leading laboratories, serving discovery, development, formulation, process research, raw material testing, and quality management laboratories across multiple industries.

CaBIG is an information network enabling all constituencies in the cancer community--researchers, physicians, and patients--to share data and knowledge. The components of CaBIG are widely applicable beyond cancer as well.

The National Cancer Institute Center for Bioinformatics, in cooperation with the NCI Technology Transfer Branch, has created the caBIG Bronze Compatibility Certification Program, which has pre-set guidelines and requirements in the areas of caBIG compatibility.

Related Links:
LabVantage
Cancer Biomedical Informatics Grid
National Cancer Institute Center for Bioinformatics



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Immunofluorescence Analyzer
IFA System
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study design and workflow (Parankusham H, Vanderlip C, Birkenbihl C, et al. A two-stage plasma biomarker algorithm reduces amyloid PET use and the p-Tau217 gray zone. Annals of Clinical and Translational Neurology. Published online October 19, 2026. doi:10.1002/acn3.70560)

Two-Step Blood Testing Approach Reduces Uncertainty in Amyloid Assessment

Blood-based biomarkers offer a more accessible, less expensive way to detect Alzheimer’s-related brain changes than traditional methods such as amyloid-beta positron emission tomography (Aβ-PET).... Read more

Molecular Diagnostics

view channel
Image: Tumor DNA is extracted from a pathology sample, and normal DNA is extracted from the buffy coat. Both samples undergo WGS to generate the patient-specific mutational signature. At each follow-up, ctDNA extracted from plasma undergoes WGS and is analyzed using a patient-derived signature and an artificial intelligence (AI) pattern recognition algorithm. FFPE: formalin fixed, paraffin embedded. (Snuderl M, Smadbeck J, Wilkins R, et al. The Journal of Molecular Diagnostics, 2026. DOI: 10.1016/j.jmoldx.2026.07.003)

Liquid Biopsy Detects Lung Cancer Recurrence Signals Months Before Imaging

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and remains a major cause of cancer-related death. Early-stage tumors are often treated surgically, but recurrence can still occur... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: HETA Quality Control identifies slide quality issues before analysis, while HETA Tumor Detect annotates tumor regions and flags slides likely to contain tumor during scanning. (Photo courtesy of Aignostics)

AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

Pathology laboratories often rely on visual review of tissue slides to assess quality, identify tumors, count mitoses, and estimate tumor content. These tasks can be time-consuming and vary between readers,... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.